Wellgistics Health (NASDAQ:WGRX) Releases Earnings Results

Key Points

• Wellgistics Health (NASDAQ:WGRX) reported an earnings per share (EPS) of (-0.11) for the most recent quarter.
• The company's stock saw a significant trading volume of 4,293,269 shares compared to its average of 1,399,547 shares, with the stock price reaching $0.8704.
• Wall Street analysts downgraded Wellgistics Health from a "hold" rating to a "sell" rating on July 26th.

Wellgistics Health (NASDAQ:WGRX - Get Free Report) announced its earnings results on Tuesday. The company reported ($0.11) EPS for the quarter, Zacks reports. The company had revenue of $7.79 million during the quarter.

Wellgistics Health Stock Performance

Shares of WGRX stock traded up $0.1885 on Friday, hitting $0.9450. The stock had a trading volume of 1,983,946 shares, compared to its average volume of 5,260,685. The company has a debt-to-equity ratio of 11.16, a current ratio of 0.32 and a quick ratio of 0.15. The company's 50 day moving average is $0.93. Wellgistics Health has a 12-month low of $0.6150 and a 12-month high of $7.04.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen upgraded Wellgistics Health from a "sell" rating to a "hold" rating in a research report on Friday.

Wellgistics Health Company Profile

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services.